---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-23-032991"
form_type: "8-K"
ticker: null
cik: "0001401395"
company_name: "Neptune Wellness Solutions Inc."
filed_at: "2023-11-24T23:59:59+00:00"
generated_at: "2026-06-07T21:49:23.513897+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Neptune subsidiary Biodroga enters $3M accounts receivable and inventory financing with Alterna Capital

## Summary
- Biodroga sold eligible accounts receivable to Alterna Capital Solutions; initial max amount $3M, can increase to $8M.
- Inventory Finance Rider provides advances up to 75% of eligible inventory value at lower of cost or market.
- Fees include prime plus 1% (min 9.5% per annum) on funds used; $20 per wire and other customary costs.
- Initial 12-month term with automatic annual renewal; parent Neptune provided a Commercial Guaranty.
- Collateral includes accounts receivable and inventory; security interest granted to Alterna.

## SEC filing metadata
- accession: 0001437749-23-032991
- form_type: 8-K
- cik: 0001401395
- company_name: Neptune Wellness Solutions Inc.
- filed_at: 2023-11-24T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 2.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1401395/000143774923032991/0001437749-23-032991-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1401395/000143774923032991/nept20231124_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-23-032991
- JSON: https://secwatch.observer/filing/0001437749-23-032991.json
- Plain text: https://secwatch.observer/filing/0001437749-23-032991.txt

## Key facts
- Debt Financings
  Neptune Wellness Solutions Inc. incurred credit facility of $3 million with Alterna Capital Solutions LLC at prime plus 1% with a minimum interest rate of 9.5% per annum maturing initial twelve (12) month term, followed by automatic annual renewal terms.
  - Instrument: credit facility
  - Principal: $3 million
  - Counterparty: Alterna Capital Solutions LLC
  - Rate: prime plus 1% with a minimum interest rate of 9.5% per annum
  - Maturity: initial twelve (12) month term, followed by automatic annual renewal terms
  - Event: incurrence
  source text: (the “Company”) executed an Invoice Purchase and Sale Agreement (the “PSA”) with Alterna Capital Solutions LLC (the “Lender”), dated November 8, 2023, providing for the purchase by the Lender of certain of Biodroga’s accounts receivable.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1401395/000143774923032991/0001437749-23-032991-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.